ATE466015T1 - Verfahren zur herstellung von phenserin und dessen analogon - Google Patents

Verfahren zur herstellung von phenserin und dessen analogon

Info

Publication number
ATE466015T1
ATE466015T1 AT02790077T AT02790077T ATE466015T1 AT E466015 T1 ATE466015 T1 AT E466015T1 AT 02790077 T AT02790077 T AT 02790077T AT 02790077 T AT02790077 T AT 02790077T AT E466015 T1 ATE466015 T1 AT E466015T1
Authority
AT
Austria
Prior art keywords
phenserine
analogue
producing
compounds
isocyanate
Prior art date
Application number
AT02790077T
Other languages
English (en)
Inventor
Joerg Bruening
Original Assignee
Axonyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axonyx Inc filed Critical Axonyx Inc
Application granted granted Critical
Publication of ATE466015T1 publication Critical patent/ATE466015T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02790077T 2002-01-09 2002-12-11 Verfahren zur herstellung von phenserin und dessen analogon ATE466015T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/042,586 US6495700B1 (en) 2002-01-09 2002-01-09 Process for producing phenserine and its analog
PCT/US2002/039537 WO2003059909A1 (en) 2002-01-09 2002-12-11 A process for producing phenserine and its analog

Publications (1)

Publication Number Publication Date
ATE466015T1 true ATE466015T1 (de) 2010-05-15

Family

ID=21922704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790077T ATE466015T1 (de) 2002-01-09 2002-12-11 Verfahren zur herstellung von phenserin und dessen analogon

Country Status (15)

Country Link
US (1) US6495700B1 (de)
EP (1) EP1463729B1 (de)
JP (1) JP2005514459A (de)
KR (2) KR100712003B1 (de)
CN (1) CN1301995C (de)
AT (1) ATE466015T1 (de)
AU (1) AU2002353102B2 (de)
BR (1) BRPI0215492A2 (de)
CA (1) CA2470560C (de)
DE (1) DE60236207D1 (de)
HR (1) HRP20040606A2 (de)
HU (1) HUP0500747A3 (de)
IL (1) IL162827A0 (de)
PL (1) PL374240A1 (de)
WO (1) WO2003059909A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795307B2 (en) 2003-10-21 2010-09-14 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US20070167509A1 (en) * 2005-06-14 2007-07-19 Joseph Araujo Use of phenserine and analogs to treat behavioral problems and improve trainability
EP1928437A2 (de) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese mittels muscarinrezeptormodulation
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP2068872A1 (de) * 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
EA202092673A3 (ru) 2010-02-09 2021-05-31 Дзе Джонс Хопкинс Юниверсити Способы и композиции для улучшения когнитивной функции
US20120225922A1 (en) 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
CA2986598C (en) 2015-05-22 2023-09-26 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
US12042482B2 (en) 2015-08-14 2024-07-23 Annovis Bio, Inc. Methods of treatment or prevention of acute brain or nerve injuries
US20180338950A1 (en) 2017-05-24 2018-11-29 Qr Pharma, Inc. Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis Via Administration of Posiphen to Healthy or Sick Humans
WO2022245843A1 (en) 2021-05-18 2022-11-24 Annovis Bio, Inc. Inhibition of neurological injuries due to infections via administration of butanetap and analogs thereof
WO2025255358A1 (en) * 2024-06-06 2025-12-11 Annovis Bio, Inc. Solid forms of posiphen d-tartrate and processes of preparation thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
IT1199076B (it) 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US5306825A (en) 1984-03-01 1994-04-26 Consiglio Nazionale Delle Ricerche Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process
US4791107A (en) 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US5187165A (en) 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US5260452A (en) 1989-11-03 1993-11-09 Hoechst-Roussel Pharmaceuticals Inc. 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof
US5077289A (en) 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5177101A (en) 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5705657A (en) 1991-02-14 1998-01-06 Labochim Laboratorio Chimico Internazionale S.P.A. Isocyanate process for the preparation of 1,3A,8-trimethyl-1,2,3,3A, 8, 8A-hexahydro-pyrrole 2,3-B! indol-5 (3AS, 8AR) -hepthylcarbamate
EP0499959A1 (de) 1991-02-18 1992-08-26 Bromine Compounds Ltd. Verfahren zur Herstellung von substituierten Haleimiden
ES2201050T3 (es) 1991-09-26 2004-03-16 The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services Compuestos que presentan una inhibicion selectiva de la acteil-colinesterasa.
US5206260A (en) 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
NZ248180A (en) * 1992-07-21 1995-02-24 Hoechst Roussel Pharma Process for the preparation of physostigmine carbamate derivatives
US5302721A (en) 1992-07-21 1994-04-12 Hoechst-Roussel Pharmaceuticals Incorporated Method of preparation of physostigmine carbamate derivatives from eseretholes
US5409948A (en) 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers

Also Published As

Publication number Publication date
EP1463729A4 (de) 2005-06-29
JP2005514459A (ja) 2005-05-19
CN1301995C (zh) 2007-02-28
AU2002353102B2 (en) 2007-05-24
HRP20040606A2 (en) 2004-12-31
DE60236207D1 (de) 2010-06-10
US6495700B1 (en) 2002-12-17
HUP0500747A3 (en) 2009-05-28
CA2470560C (en) 2007-05-15
KR20060097772A (ko) 2006-09-15
HK1075659A1 (en) 2005-12-23
HUP0500747A2 (hu) 2005-11-28
KR100712003B1 (ko) 2007-05-02
IL162827A0 (en) 2005-11-20
BRPI0215492A2 (pt) 2016-07-05
AU2002353102A1 (en) 2003-07-30
KR20040072711A (ko) 2004-08-18
WO2003059909A1 (en) 2003-07-24
EP1463729A1 (de) 2004-10-06
CN1612880A (zh) 2005-05-04
CA2470560A1 (en) 2003-07-24
PL374240A1 (en) 2005-10-03
EP1463729B1 (de) 2010-04-28

Similar Documents

Publication Publication Date Title
ATE466015T1 (de) Verfahren zur herstellung von phenserin und dessen analogon
ATE534629T1 (de) Verfahren und verbindungen zur herstellung von cc-1065-analoga
ATE501126T1 (de) Verfahren zur herstellung von rosuvastatin
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
ATE381727T1 (de) Verfahren zur multiphotonen-photosensibilisierung
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE60317651D1 (de) Verfahren zur herstellung von hochmolekularen verbindungen für photoresists
ATE360653T1 (de) Verfahren zur herstellung von polyisobutenen
DE502004005626D1 (de) Verfahren zur herstellung von organoacylphosphiten
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE431339T1 (de) Verfahren zur herstellung von n-amino- substituierten heterocyclischen verbindungen
ATE470657T1 (de) Verfahren zur herstellung von isocyanaten
ATE322495T1 (de) Verfahren zur herstellung von kristallinem n- formimidoylthienamycin-monohydrat (imipenem- monohydrat)
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ATE528280T1 (de) Verfahren zur herstellung von triethanolamin
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE297404T1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
ATE425143T1 (de) Verfahren zur herstellung von indolen